Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference23 articles.
1. Restenosis after percutaneous angioplasty: the role of vascular inflammation;Schillinger;Vasc Health Risk Manag,2005
2. Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel?;Speck;Circ Cardiovasc Interv,2012
3. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty;Scheinert;J Am Coll Cardiol Intv,2014
4. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease;Rosenfield;N Engl J Med,2015
5. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial;Tepe;Circulation,2015
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inhibition of restenosis after balloon injury in rabbit vessels by integrin αvβ3-targeted 10058-F4 nanoparticles;Journal of Experimental Nanoscience;2024-08-15
2. Long-Term Clinical Effectiveness and Associated Factors of Drug-Coated Balloon for Long and Short Femoropopliteal Lesion;2024-06-13
3. The BioMimics 3D Helical Centreline Nitinol Stent in Chronic Limb Threatening Ischaemia and Complex Lesions: Three Year Outcomes of the MIMICS-3D Registry;European Journal of Vascular and Endovascular Surgery;2024-06
4. A Segmentalized Approach to Femoropopliteal Chronic Total Occlusions;JACC: Cardiovascular Interventions;2024-03
5. Intraluminal vs Subintimal Drug-Coated Balloon Angioplasty for the Treatment of Femoropopliteal Chronic Total Occlusions;JACC: Cardiovascular Interventions;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3